Abstract
Author(s): AGATA SIDÅO-STAWOWY1, KATARZYNA NOWAK1, SYLWIA NOWAK1,AGNIESZKA DROSDZOL-COP1, VIOLETTA SKRZYPULEC-PLINTA1, ANNA JANIK
Uterine fibroids are benign, hormone-dependent tumors deriving from the smooth muscle tissue.They occur in 20-50% women at the age of 35 and 70% at the age of 50. The most commonsymptoms of uterine fibroids include: heavy, prolonged menstrual bleeding, pain and thetightness in the pelvis. Methods of treatment of uterine fibroids can be divided into: pharma-cological, surgical and minimally invasive, such as - uterine artery embolization, laparoscopicuterine artery coagulation. Up to date, surgical procedures (hysterectomy or myomectomy) havebeen the dominant managements but recently uterine artery embolization have also been takeninto consideration. In connection with the late maternity there are growing need for effectivepharmacological treatment of uterine fibroids (Gonadotropin Releasing Hormone, Ulipristalacetate), which can replace traditional surgical methods.